S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
NYSEARCA:SBIO

ALPS Medical Breakthroughs ETF - SBIO Stock Forecast, Price & News

$32.25
-0.12 (-0.37%)
(As of 01/26/2023 12:00 AM ET)
Add
Today's Range
$32.14
$32.49
50-Day Range
$28.38
$32.37
52-Week Range
$23.58
$37.38
Volume
6,919 shs
Average Volume
9,001 shs
Market Capitalization
$115.46 million
P/E Ratio
N/A
Dividend Yield
0.00%
Price Target
N/A

Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ALPS
Fund NameALPS Medical Breakthroughs ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:SBIO
Inception Date12/31/2014
Fund ManagerRyan Mischker, Andrew Hicks
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkPoliwogg Medical Breakthroughs Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$115.97 million
Average Daily Volume$10,590.80
Discount/Premium-0.07%

ETF Expenses

Management Fee0.50%
Other Expenses0.00%
Total Expenses0.50%
Fee Waiver0.00%
Net Expenses0.50%

Administrator, Advisor and Custodian

AdministratorALPS Fund Services, Inc.
AdvisorALPS Advisors, Inc.
CustodianState Street Bank and Trust Company
DistributorALPS Portfolio Solutions Distributor, Inc.
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerGTS

Geographic Exposure of SBIO

Currency Exposure of SBIO

Sector Exposure of SBIO

Industry Exposure of SBIO














SBIO Stock - Frequently Asked Questions

How have SBIO shares performed in 2023?

ALPS Medical Breakthroughs ETF's stock was trading at $30.38 at the start of the year. Since then, SBIO stock has increased by 6.2% and is now trading at $32.25.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Novavax (NVAX), Alibaba Group (BABA), Cidara Therapeutics (CDTX) and Quest Diagnostics (DGX).

What is ALPS Medical Breakthroughs ETF's stock symbol?

ALPS Medical Breakthroughs ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "SBIO."

Who are ALPS Medical Breakthroughs ETF's major shareholders?

ALPS Medical Breakthroughs ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include DAVENPORT & Co LLC (17.22%).

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ALPS Medical Breakthroughs ETF's stock price today?

One share of SBIO stock can currently be purchased for approximately $32.25.

How much money does ALPS Medical Breakthroughs ETF make?

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) has a market capitalization of $115.46 million.

This page (NYSEARCA:SBIO) was last updated on 1/27/2023 by MarketBeat.com Staff